LTRN Lantern Pharma Inc
Company Analysis
Latest News
🟢 Lantern Pharma is trading 9.66% up in pre-market with no identified company-specific catalyst
Lantern Pharma is trading 9.66% up at $1.64, with no new company-specific catalyst identified for September 22, 2026. - The latest notable announcement is a...
🟢 Lantern Pharma is trading 10.32% up in after-hours trading
Lantern Pharma is trading 10.32% up at $1.71 after-hours, with no clear company-specific catalyst identified. - Shares closed at $1.55 on September 18, 2026,...
🔴 Lantern Pharma is trading 5.26% down today — immediate cause unclear
Lantern Pharma is trading at $1.62 (-5.26%), with no clear company-specific negative catalyst identified for September 18, 2026. - The latest announcement is...
🔴 Lantern Pharma is trading 11% down today with no clear company-specific negative catalyst identified
Lantern Pharma is trading 11% down now at $1.72, with no clear company-specific negative catalyst identified. - The September 16, 2026, rally has reversed. -...
🔴 Lantern Pharma is trading 9.33% down today after September 16's advance; catalyst unclear
Lantern Pharma is trading at $1.75, down 9.33%, with no confirmed company-specific announcement explaining the September 17 decline. - The company announced a...
🟢 Lantern Pharma is trading 14.51% up today in pre-market with catalyst still unconfirmed
Lantern Pharma is trading 14.51% up at $2.21 in pre-market, with the catalyst unconfirmed. - The stock rose 13.53% to $1.93 on September 16. - No...
🟢 Lantern Pharma is trading 12.35% up today with no confirmed catalyst
Lantern Pharma is trading 12.35% up at $1.91 on September 16, 2026, despite broader biotech weakness; the move remains unexplained. - No company-specific...
🟢 Lantern Pharma is trading 7.7% up today; no catalyst confirmed
Lantern Pharma is trading 7.7% up at $1.83, after closing at $1.70 on September 15, 2026; the reason remains unconfirmed. - No company-specific announcement...
🔴 Lantern Pharma is trading 8% down today in pre-market; immediate catalyst remains unclear
Lantern Pharma is trading at $1.62, down 7.95%, while the immediate catalyst remains unclear. - No clear company-specific announcement was identified for...
🔴 Lantern Pharma is trading 5% down in pre-market amid broader risk-off conditions
Lantern Pharma is trading 5.08% down now at $1.68, with the decline appearing consistent with broader risk-off conditions. - No clear company-specific...
🟢 Lantern Pharma is trading 5.51% up today with no clear catalyst identified
Lantern Pharma is trading 5.51% up at $2.01, with no clear catalyst identified. - No September 8, 2026 company-specific announcement, filing, analyst action,...
🟢 Lantern Pharma is trading 6.42% up in pre-market with no clear catalyst identified
Lantern Pharma is trading 6.42% up at $1.99 after closing at $1.87 on September 3, 2026, with no clear catalyst identified. - No new company-specific...
🔴 Lantern Pharma is trading 5.18% down today with no clear catalyst identified
Lantern Pharma is trading 5.18% down at $1.83 after falling from the September 2, 2026 close of $1.93; the cause remains unclear despite broader equities and...
🔴 Lantern Pharma is trading 5.69% down today — no clear company-specific catalyst identified
Lantern Pharma is trading 5.69% down at $1.91 after no clear company-specific catalyst was identified for September 2, 2026. - Recent coverage centers on the...
🔴 Lantern Pharma is trading 10.4% down in pre-market; reason unconfirmed
Lantern Pharma is trading 10.4% down at $1.81 in pre-market, with no clear company-specific announcement identified for September 2, 2026; the reason remains...
🟢 Lantern Pharma is trading 5.5% up today as Nasdaq and S&P 500 rise
Lantern Pharma is trading 5.5% up at $2.30 amid a broadly positive August 27, 2026 session. - The Nasdaq Composite is up 1.34%, while the S&P 500 is up 0.59%,...
🔴 Lantern Pharma is trading 8.26% down in pre-market — no specific catalyst identified
Lantern Pharma is trading 8.26% down at $2.00, versus the August 25, 2026 close of $2.18; no specific catalyst was identified. - No new company-specific...
🟢 Lantern Pharma rises 5.5% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🔴 Lantern Pharma is trading 10.26% down today as no clear catalyst explains decline
Lantern Pharma is trading at $2.10, down 10.26%, with no confirmed catalyst for the August 24 decline. - Weakness extended after the August 21, 2026 close at...
🔴 Lantern Pharma is trading 6.4% down today with no clear company-specific catalyst identified
Lantern Pharma is trading at $2.19, down -6.41%, with no clear company-specific announcement or catalyst identified for August 24, 2026. - Investor sentiment...